Based on 5 analysts giving stock ratings to Metagenomi Inc in the past month.
In the current month, MGX has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MGX average Analyst price target in the last month is 7.000.
Based on analysts' estimates, MGX EPS is projected to reach -0.564 in FY2026Q4, following reported EPS of -0.559 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.56, while Metagenomi IncMGX's earnings per share (EPS) for the previous quarter was USD -0.73. EPS for the next quarter is expected at USD -0.56.